Search results
364 results found
Moving innovations from hype to healthcareBlogAt 'From Hype to Healthcare', we explored the many policy approaches to navigating from the excitement surrounding scientific and technological innovations, and their predicted potential for health.
First gene silencing drug offered on NHSBlogA new type of medicine that uses an approach called ‘gene silencing’ has been approved for use in the National Health Service (NHS) in England.
Looking to the future of breast cancer preventionBlogDr Sowmiya Moorthie provides an overview of our report to the EU on looking to the future of breast cancer prevention.
Point of care genomic tests in infectious diseaseBlogMedical student, Simran Goyal, investigated point of care medical devices for infectious diseases whilst on placement at the PHG Foundation. Here she sets out what she found
Developing the cancer-screening services of the futureBlogAn interim report from the independent review of cancer screening was published last week. Dr Laura Blackburn reviews its findings so far.
Can genomic medicine attract, recruit and retain clinical bioinformaticians?BlogGenomic medicine demands a range of new workforce skills, and the good news is that the NHS is already making progress.
New and improved innovation unit to lead on accelerated accessBlogDr Philippa Brice comments on the Department for Health and Social Care announcement of the creation of a new national unit to oversee innovation and medicines
How does the GDPR apply to genomic data?BlogColin Mitchell sets out why our work to clarify the impact of the GDPR on the use of genomic data is so necessary. The work is funded by the Information Commissioner's Office
Dementia risk prediction modelsBlogWhile substantial progress has been made dementia remains a stubbornly difficult condition to prevent and treat
CAR-T: immunotherapy for blood cancerBlogIn the UK, steps are being taken to make delivery of regenerative medicines such as CAR-T a reality – Dr Emma Johnson provides an overview of the current state of play in this promising area for cancer therapies